Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by, suppresses inflammation and downstream NF-κB activated pyroptosis pathways

Huaqiang Tao; Wenming Li; Wei Zhang; Yang Chen; Chun Zhang; Xiaolong Liang; Juan Juan Yin; Jiaxiang Bai; Gaoran Ge; Haifeng Zhang; Xing Yang; Hongxia Li; Yaozeng Xu; Yuefeng Hao; Yu Liu; Dechun Geng

doi:10.1016/j.phrs.2021.105967

Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by, suppresses inflammation and downstream NF-κB activated pyroptosis pathways

Huaqiang Tao(Soochow University), Wenming Li(Soochow University), Wei Zhang(First Affiliated Hospital of Soochow University), Yang Chen(Soochow University), Chun Zhang(Suzhou Municipal Hospital), Xiaolong Liang(Soochow University), Juan Juan Yin(Nanjing Medical University), Jiaxiang Bai(First Affiliated Hospital of Soochow University), Gaoran Ge(First Affiliated Hospital of Soochow University), Haifeng Zhang(First Affiliated Hospital of Soochow University), Xing Yang(Suzhou Municipal Hospital), Hongxia Li(Soochow University), Yaozeng Xu(First Affiliated Hospital of Soochow University), Yuefeng Hao(Suzhou Municipal Hospital), Yu Liu(Soochow University), Dechun Geng(First Affiliated Hospital of Soochow University)

Pharmacological Research

November 3, 2021

10.1016/j.phrs.2021.105967

Cited by 182

Abstract

Related Papers

No related papers found

Powered by citation graph analysis